Industry Research Reports

Home > Reports > Chemical & Material > Global Shingles Vaccine Market Research Report 2025

Global Shingles Vaccine Market Research Report 2025

Industry: Chemical & Material

Published Date: 2025-02-24

Pages: 81 Pages

Report ld: 4203791

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Shingles Vaccine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

MARKET SEGMENTATION

By Company

Merck
GlaxoSmithKline

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Zostavax
Shingrix

Segment by Application

Under 50 Years Old
50-60 Years Old
60-70 Years Old
Above 70 Years Old

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Shingles Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Shingles Vaccine.

The Shingles Vaccine market size, estimations, and forecasts are provided in terms of output/shipments (K Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Shingles Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Shingles Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Shingles Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Production/output, value of Shingles Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 4: Consumption of Shingles Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 10: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Shingles Vaccine Market Overview

1.1 Product Definition

1.2 Shingles Vaccine by Type

1.2.1 Global Shingles Vaccine Market Value Growth Rate Analysis by Type: 2024 VS 2031

1.2.2 Zostavax

1.2.3 Shingrix

1.3 Shingles Vaccine by Application

1.3.1 Global Shingles Vaccine Market Value Growth Rate Analysis by Application: 2024 VS 2031

1.3.2 Under 50 Years Old

1.3.3 50-60 Years Old

1.3.4 60-70 Years Old

1.3.5 Above 70 Years Old

1.4 Global Market Growth Prospects

1.4.1 Global Shingles Vaccine Production Value Estimates and Forecasts (2020-2031)

1.4.2 Global Shingles Vaccine Production Capacity Estimates and Forecasts (2020-2031)

1.4.3 Global Shingles Vaccine Production Estimates and Forecasts (2020-2031)

1.4.4 Global Shingles Vaccine Market Average Price Estimates and Forecasts (2020-2031)

1.5 Assumptions and Limitations

2 Market Competition by Manufacturers

2.1 Global Shingles Vaccine Production Market Share by Manufacturers (2020-2025)

2.2 Global Shingles Vaccine Production Value Market Share by Manufacturers (2020-2025)

2.3 Global Key Players of Shingles Vaccine, Industry Ranking, 2023 VS 2024

2.4 Global Shingles Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.5 Global Shingles Vaccine Average Price by Manufacturers (2020-2025)

2.6 Global Key Manufacturers of Shingles Vaccine, Manufacturing Base Distribution and Headquarters

2.7 Global Key Manufacturers of Shingles Vaccine, Product Offered and Application

2.8 Global Key Manufacturers of Shingles Vaccine, Date of Enter into This Industry

2.9 Shingles Vaccine Market Competitive Situation and Trends

2.9.1 Shingles Vaccine Market Concentration Rate

2.9.2 Global 5 and 10 Largest Shingles Vaccine Players Market Share by Revenue

2.10 Mergers & Acquisitions, Expansion

3 Shingles Vaccine Production by Region

3.1 Global Shingles Vaccine Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

3.2 Global Shingles Vaccine Production Value by Region (2020-2031)

3.2.1 Global Shingles Vaccine Production Value by Region (2020-2025)

3.2.2 Global Forecasted Production Value of Shingles Vaccine by Region (2026-2031)

3.3 Global Shingles Vaccine Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

3.4 Global Shingles Vaccine Production Volume by Region (2020-2031)

3.4.1 Global Shingles Vaccine Production by Region (2020-2025)

3.4.2 Global Forecasted Production of Shingles Vaccine by Region (2026-2031)

3.5 Global Shingles Vaccine Market Price Analysis by Region (2020-2025)

3.6 Global Shingles Vaccine Production and Value, Year-over-Year Growth

3.6.1 North America Shingles Vaccine Production Value Estimates and Forecasts (2020-2031)

3.6.2 Europe Shingles Vaccine Production Value Estimates and Forecasts (2020-2031)

3.6.3 China Shingles Vaccine Production Value Estimates and Forecasts (2020-2031)

3.6.4 Japan Shingles Vaccine Production Value Estimates and Forecasts (2020-2031)

4 Shingles Vaccine Consumption by Region

4.1 Global Shingles Vaccine Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

4.2 Global Shingles Vaccine Consumption by Region (2020-2031)

4.2.1 Global Shingles Vaccine Consumption by Region (2020-2025)

4.2.2 Global Shingles Vaccine Forecasted Consumption by Region (2026-2031)

4.3 North America

4.3.1 North America Shingles Vaccine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.3.2 North America Shingles Vaccine Consumption by Country (2020-2031)

4.3.3 U.S.

4.3.4 Canada

4.4 Europe

4.4.1 Europe Shingles Vaccine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.4.2 Europe Shingles Vaccine Consumption by Country (2020-2031)

4.4.3 Germany

4.4.4 France

4.4.5 U.K.

4.4.6 Italy

4.4.7 Russia

4.5 Asia Pacific

4.5.1 Asia Pacific Shingles Vaccine Consumption Growth Rate by Region: 2020 VS 2024 VS 2031

4.5.2 Asia Pacific Shingles Vaccine Consumption by Region (2020-2031)

4.5.3 China

4.5.4 Japan

4.5.5 South Korea

4.5.6 China Taiwan

4.5.7 Southeast Asia

4.5.8 India

4.6 Latin America, Middle East & Africa

4.6.1 Latin America, Middle East & Africa Shingles Vaccine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.6.2 Latin America, Middle East & Africa Shingles Vaccine Consumption by Country (2020-2031)

4.6.3 Mexico

4.6.4 Brazil

4.6.5 Turkey

4.6.6 GCC Countries

5 Segment by Type

5.1 Global Shingles Vaccine Production by Type (2020-2031)

5.1.1 Global Shingles Vaccine Production by Type (2020-2025)

5.1.2 Global Shingles Vaccine Production by Type (2026-2031)

5.1.3 Global Shingles Vaccine Production Market Share by Type (2020-2031)

5.2 Global Shingles Vaccine Production Value by Type (2020-2031)

5.2.1 Global Shingles Vaccine Production Value by Type (2020-2025)

5.2.2 Global Shingles Vaccine Production Value by Type (2026-2031)

5.2.3 Global Shingles Vaccine Production Value Market Share by Type (2020-2031)

5.3 Global Shingles Vaccine Price by Type (2020-2031)

6 Segment by Application

6.1 Global Shingles Vaccine Production by Application (2020-2031)

6.1.1 Global Shingles Vaccine Production by Application (2020-2025)

6.1.2 Global Shingles Vaccine Production by Application (2026-2031)

6.1.3 Global Shingles Vaccine Production Market Share by Application (2020-2031)

6.2 Global Shingles Vaccine Production Value by Application (2020-2031)

6.2.1 Global Shingles Vaccine Production Value by Application (2020-2025)

6.2.2 Global Shingles Vaccine Production Value by Application (2026-2031)

6.2.3 Global Shingles Vaccine Production Value Market Share by Application (2020-2031)

6.3 Global Shingles Vaccine Price by Application (2020-2031)

7 Key Companies Profiled

7.1 Merck

7.1.1 Merck Shingles Vaccine Company Information

7.1.2 Merck Shingles Vaccine Product Portfolio

7.1.3 Merck Shingles Vaccine Production, Value, Price and Gross Margin (2020-2025)

7.1.4 Merck Main Business and Markets Served

7.1.5 Merck Recent Developments/Updates

7.2 GlaxoSmithKline

7.2.1 GlaxoSmithKline Shingles Vaccine Company Information

7.2.2 GlaxoSmithKline Shingles Vaccine Product Portfolio

7.2.3 GlaxoSmithKline Shingles Vaccine Production, Value, Price and Gross Margin (2020-2025)

7.2.4 GlaxoSmithKline Main Business and Markets Served

7.2.5 GlaxoSmithKline Recent Developments/Updates

8 Industry Chain and Sales Channels Analysis

8.1 Shingles Vaccine Industry Chain Analysis

8.2 Shingles Vaccine Raw Material Supply Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.3 Shingles Vaccine Production Mode & Process Analysis

8.4 Shingles Vaccine Sales and Marketing

8.4.1 Shingles Vaccine Sales Channels

8.4.2 Shingles Vaccine Distributors

8.5 Shingles Vaccine Customer Analysis

9 Shingles Vaccine Market Dynamics

9.1 Shingles Vaccine Industry Trends

9.2 Shingles Vaccine Market Drivers

9.3 Shingles Vaccine Market Challenges

9.4 Shingles Vaccine Market Restraints

10 Research Findings and Conclusion

11 Methodology and Data Source

11.1 Methodology/Research Approach

11.1.1 Research Programs/Design

11.1.2 Market Size Estimation

11.1.3 Market Breakdown and Data Triangulation

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Author List

11.4 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Shingles Vaccine Market Value by Type, (US$ Million) & (2024 VS 2031)

Table 2. Global Shingles Vaccine Market Value by Application, (US$ Million) & (2024 VS 2031)

Table 3. Global Shingles Vaccine Production Capacity (K Doses) by Manufacturers in 2024

Table 4. Global Shingles Vaccine Production by Manufacturers (2020-2025) & (K Doses)

Table 5. Global Shingles Vaccine Production Market Share by Manufacturers (2020-2025)

Table 6. Global Shingles Vaccine Production Value by Manufacturers (2020-2025) & (US$ Million)

Table 7. Global Shingles Vaccine Production Value Share by Manufacturers (2020-2025)

Table 8. Global Key Players of Shingles Vaccine, Industry Ranking, 2023 VS 2024

Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Shingles Vaccine as of 2024)

Table 10. Global Market Shingles Vaccine Average Price by Manufacturers (USD/Dose) & (2020-2025)

Table 11. Global Key Manufacturers of Shingles Vaccine, Manufacturing Base Distribution and Headquarters

Table 12. Global Key Manufacturers of Shingles Vaccine, Product Offered and Application

Table 13. Global Key Manufacturers of Shingles Vaccine, Date of Enter into This Industry

Table 14. Global Shingles Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Shingles Vaccine Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Shingles Vaccine Production Value (US$ Million) by Region (2020-2025)

Table 18. Global Shingles Vaccine Production Value Market Share by Region (2020-2025)

Table 19. Global Shingles Vaccine Production Value (US$ Million) Forecast by Region (2026-2031)

Table 20. Global Shingles Vaccine Production Value Market Share Forecast by Region (2026-2031)

Table 21. Global Shingles Vaccine Production Comparison by Region: 2020 VS 2024 VS 2031 (K Doses)

Table 22. Global Shingles Vaccine Production (K Doses) by Region (2020-2025)

Table 23. Global Shingles Vaccine Production Market Share by Region (2020-2025)

Table 24. Global Shingles Vaccine Production (K Doses) Forecast by Region (2026-2031)

Table 25. Global Shingles Vaccine Production Market Share Forecast by Region (2026-2031)

Table 26. Global Shingles Vaccine Market Average Price (USD/Dose) by Region (2020-2025)

Table 27. Global Shingles Vaccine Market Average Price (USD/Dose) by Region (2026-2031)

Table 28. Global Shingles Vaccine Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (K Doses)

Table 29. Global Shingles Vaccine Consumption by Region (2020-2025) & (K Doses)

Table 30. Global Shingles Vaccine Consumption Market Share by Region (2020-2025)

Table 31. Global Shingles Vaccine Forecasted Consumption by Region (2026-2031) & (K Doses)

Table 32. Global Shingles Vaccine Forecasted Consumption Market Share by Region (2026-2031)

Table 33. North America Shingles Vaccine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (K Doses)

Table 34. North America Shingles Vaccine Consumption by Country (2020-2025) & (K Doses)

Table 35. North America Shingles Vaccine Consumption by Country (2026-2031) & (K Doses)

Table 36. Europe Shingles Vaccine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (K Doses)

Table 37. Europe Shingles Vaccine Consumption by Country (2020-2025) & (K Doses)

Table 38. Europe Shingles Vaccine Consumption by Country (2026-2031) & (K Doses)

Table 39. Asia Pacific Shingles Vaccine Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (K Doses)

Table 40. Asia Pacific Shingles Vaccine Consumption by Region (2020-2025) & (K Doses)

Table 41. Asia Pacific Shingles Vaccine Consumption by Region (2026-2031) & (K Doses)

Table 42. Latin America, Middle East & Africa Shingles Vaccine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (K Doses)

Table 43. Latin America, Middle East & Africa Shingles Vaccine Consumption by Country (2020-2025) & (K Doses)

Table 44. Latin America, Middle East & Africa Shingles Vaccine Consumption by Country (2026-2031) & (K Doses)

Table 45. Global Shingles Vaccine Production (K Doses) by Type (2020-2025)

Table 46. Global Shingles Vaccine Production (K Doses) by Type (2026-2031)

Table 47. Global Shingles Vaccine Production Market Share by Type (2020-2025)

Table 48. Global Shingles Vaccine Production Market Share by Type (2026-2031)

Table 49. Global Shingles Vaccine Production Value (US$ Million) by Type (2020-2025)

Table 50. Global Shingles Vaccine Production Value (US$ Million) by Type (2026-2031)

Table 51. Global Shingles Vaccine Production Value Market Share by Type (2020-2025)

Table 52. Global Shingles Vaccine Production Value Market Share by Type (2026-2031)

Table 53. Global Shingles Vaccine Price (USD/Dose) by Type (2020-2025)

Table 54. Global Shingles Vaccine Price (USD/Dose) by Type (2026-2031)

Table 55. Global Shingles Vaccine Production (K Doses) by Application (2020-2025)

Table 56. Global Shingles Vaccine Production (K Doses) by Application (2026-2031)

Table 57. Global Shingles Vaccine Production Market Share by Application (2020-2025)

Table 58. Global Shingles Vaccine Production Market Share by Application (2026-2031)

Table 59. Global Shingles Vaccine Production Value (US$ Million) by Application (2020-2025)

Table 60. Global Shingles Vaccine Production Value (US$ Million) by Application (2026-2031)

Table 61. Global Shingles Vaccine Production Value Market Share by Application (2020-2025)

Table 62. Global Shingles Vaccine Production Value Market Share by Application (2026-2031)

Table 63. Global Shingles Vaccine Price (USD/Dose) by Application (2020-2025)

Table 64. Global Shingles Vaccine Price (USD/Dose) by Application (2026-2031)

Table 65. Merck Shingles Vaccine Company Information

Table 66. Merck Shingles Vaccine Specification and Application

Table 67. Merck Shingles Vaccine Production (K Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 68. Merck Main Business and Markets Served

Table 69. Merck Recent Developments/Updates

Table 70. GlaxoSmithKline Shingles Vaccine Company Information

Table 71. GlaxoSmithKline Shingles Vaccine Specification and Application

Table 72. GlaxoSmithKline Shingles Vaccine Production (K Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 73. GlaxoSmithKline Main Business and Markets Served

Table 74. GlaxoSmithKline Recent Developments/Updates

Table 75. Key Raw Materials Lists

Table 76. Raw Materials Key Suppliers Lists

Table 77. Shingles Vaccine Distributors List

Table 78. Shingles Vaccine Customers List

Table 79. Shingles Vaccine Market Trends

Table 80. Shingles Vaccine Market Drivers

Table 81. Shingles Vaccine Market Challenges

Table 82. Shingles Vaccine Market Restraints

Table 83. Research Programs/Design for This Report

Table 84. Key Data Information from Secondary Sources

Table 85. Key Data Information from Primary Sources

Table 86. Authors List of This Report

List of Figures

Figure 1. Product Picture of Shingles Vaccine

Figure 2. Global Shingles Vaccine Market Value by Type, (US$ Million) & (2020-2031)

Figure 3. Global Shingles Vaccine Market Share by Type: 2024 VS 2031

Figure 4. Zostavax Product Picture

Figure 5. Shingrix Product Picture

Figure 6. Global Shingles Vaccine Market Value by Application, (US$ Million) & (2020-2031)

Figure 7. Global Shingles Vaccine Market Share by Application: 2024 VS 2031

Figure 8. Under 50 Years Old

Figure 9. 50-60 Years Old

Figure 10. 60-70 Years Old

Figure 11. Above 70 Years Old

Figure 12. Global Shingles Vaccine Production Value (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Shingles Vaccine Production Value (US$ Million) & (2020-2031)

Figure 14. Global Shingles Vaccine Production Capacity (K Doses) & (2020-2031)

Figure 15. Global Shingles Vaccine Production (K Doses) & (2020-2031)

Figure 16. Global Shingles Vaccine Average Price (USD/Dose) & (2020-2031)

Figure 17. Shingles Vaccine Report Years Considered

Figure 18. Shingles Vaccine Production Share by Manufacturers in 2024

Figure 19. Global Shingles Vaccine Production Value Share by Manufacturers (2024)

Figure 20. Shingles Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. The Global 5 and 10 Largest Players: Market Share by Shingles Vaccine Revenue in 2024

Figure 22. Global Shingles Vaccine Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 23. Global Shingles Vaccine Production Value Market Share by Region: 2020 VS 2024 VS 2031

Figure 24. Global Shingles Vaccine Production Comparison by Region: 2020 VS 2024 VS 2031 (K Doses)

Figure 25. Global Shingles Vaccine Production Market Share by Region: 2020 VS 2024 VS 2031

Figure 26. North America Shingles Vaccine Production Value (US$ Million) Growth Rate (2020-2031)

Figure 27. Europe Shingles Vaccine Production Value (US$ Million) Growth Rate (2020-2031)

Figure 28. China Shingles Vaccine Production Value (US$ Million) Growth Rate (2020-2031)

Figure 29. Japan Shingles Vaccine Production Value (US$ Million) Growth Rate (2020-2031)

Figure 30. Global Shingles Vaccine Consumption by Region: 2020 VS 2024 VS 2031 (K Doses)

Figure 31. Global Shingles Vaccine Consumption Market Share by Region: 2020 VS 2024 VS 2031

Figure 32. North America Shingles Vaccine Consumption and Growth Rate (2020-2031) & (K Doses)

Figure 33. North America Shingles Vaccine Consumption Market Share by Country (2020-2031)

Figure 34. U.S. Shingles Vaccine Consumption and Growth Rate (2020-2031) & (K Doses)

Figure 35. Canada Shingles Vaccine Consumption and Growth Rate (2020-2031) & (K Doses)

Figure 36. Europe Shingles Vaccine Consumption and Growth Rate (2020-2031) & (K Doses)

Figure 37. Europe Shingles Vaccine Consumption Market Share by Country (2020-2031)

Figure 38. Germany Shingles Vaccine Consumption and Growth Rate (2020-2031) & (K Doses)

Figure 39. France Shingles Vaccine Consumption and Growth Rate (2020-2031) & (K Doses)

Figure 40. U.K. Shingles Vaccine Consumption and Growth Rate (2020-2031) & (K Doses)

Figure 41. Italy Shingles Vaccine Consumption and Growth Rate (2020-2031) & (K Doses)

Figure 42. Russia Shingles Vaccine Consumption and Growth Rate (2020-2031) & (K Doses)

Figure 43. Asia Pacific Shingles Vaccine Consumption and Growth Rate (2020-2031) & (K Doses)

Figure 44. Asia Pacific Shingles Vaccine Consumption Market Share by Region (2020-2031)

Figure 45. China Shingles Vaccine Consumption and Growth Rate (2020-2031) & (K Doses)

Figure 46. Japan Shingles Vaccine Consumption and Growth Rate (2020-2031) & (K Doses)

Figure 47. South Korea Shingles Vaccine Consumption and Growth Rate (2020-2031) & (K Doses)

Figure 48. China Taiwan Shingles Vaccine Consumption and Growth Rate (2020-2031) & (K Doses)

Figure 49. Southeast Asia Shingles Vaccine Consumption and Growth Rate (2020-2031) & (K Doses)

Figure 50. India Shingles Vaccine Consumption and Growth Rate (2020-2031) & (K Doses)

Figure 51. Latin America, Middle East & Africa Shingles Vaccine Consumption and Growth Rate (2020-2031) & (K Doses)

Figure 52. Latin America, Middle East & Africa Shingles Vaccine Consumption Market Share by Country (2020-2031)

Figure 53. Mexico Shingles Vaccine Consumption and Growth Rate (2020-2031) & (K Doses)

Figure 54. Brazil Shingles Vaccine Consumption and Growth Rate (2020-2031) & (K Doses)

Figure 55. Turkey Shingles Vaccine Consumption and Growth Rate (2020-2031) & (K Doses)

Figure 56. GCC Countries Shingles Vaccine Consumption and Growth Rate (2020-2031) & (K Doses)

Figure 57. Global Production Market Share of Shingles Vaccine by Type (2020-2031)

Figure 58. Global Production Value Market Share of Shingles Vaccine by Type (2020-2031)

Figure 59. Global Shingles Vaccine Price (USD/Dose) by Type (2020-2031)

Figure 60. Global Production Market Share of Shingles Vaccine by Application (2020-2031)

Figure 61. Global Production Value Market Share of Shingles Vaccine by Application (2020-2031)

Figure 62. Global Shingles Vaccine Price (USD/Dose) by Application (2020-2031)

Figure 63. Shingles Vaccine Value Chain

Figure 64. Channels of Distribution (Direct Vs Distribution)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Shingles Vaccine market? zhanKai

The top companies in the global Shingles Vaccine market are Merck、GlaxoSmithKline.

Related Reports

Shingles Vaccine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Shingles Vaccine was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 118
USD 3950.00
(Single User License)
Global Shingles Vaccine Market Research Report 2026
The global Shingles Vaccine market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-27
Pages: 122
USD 2900.00
(Single User License)
Global Shingles Vaccine Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Shingles Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-26
Pages: 129
USD 4900.00
(Single User License)
Global Shingles Vaccine Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Shingles Vaccine market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 65
USD 4250.00
(Single User License)
Shingles Vaccine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Shingles Vaccine was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 80
USD 3950.00
(Single User License)
Global Shingles Vaccine Market Insights, Forecast to 2030
The global Shingles Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published Date: 2024-04-19
Pages: 72
USD 4900.00
(Single User License)
Shingles Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Shingles Vaccine was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-24
Pages: 85
USD 3950.00
(Single User License)
Global Shingles Vaccine Market Research Report 2024
The global Shingles Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-05
Pages: 84
USD 2900.00
(Single User License)

Shingles Vaccine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Shingles Vaccine was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 118
USD 3950.00 (Single User License)
Global Shingles Vaccine Market Research Report 2026
The global Shingles Vaccine market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-27
Pages: 122
USD 2900.00 (Single User License)
Global Shingles Vaccine Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Shingles Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-26
Pages: 129
USD 4900.00 (Single User License)
Global Shingles Vaccine Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Shingles Vaccine market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 65
USD 4250.00 (Single User License)
Shingles Vaccine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Shingles Vaccine was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 80
USD 3950.00 (Single User License)
Global Shingles Vaccine Market Insights, Forecast to 2030
The global Shingles Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published: 2024-04-19
Pages: 72
USD 4900.00 (Single User License)
Shingles Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Shingles Vaccine was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-24
Pages: 85
USD 3950.00 (Single User License)
Global Shingles Vaccine Market Research Report 2024
The global Shingles Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-05
Pages: 84
USD 2900.00 (Single User License)